Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Medicinas Complementares
Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Eksp Klin Farmakol ; 69(3): 63-7, 2006.
Artigo em Russo | MEDLINE | ID: mdl-16878504

RESUMO

The safety of the new enterosorbent noolit has been evaluated within the framework of its preclinical characterization. Single introduction of noolit to rats and mice (females and males) in maximum doses for intragastric administration (5.0 - 20.0 g/kg) does not lead to the loss of experimental animals. Single administration of large doses (5 - 40 times the effective dose) can reduce the growth of the total body weight and lead to the development of nonlethal pathological changes of hemopoietic organs, which is manifested by a weak regenerative anemia (5% of cases); neutrophile, eosinophile, and basophile leukocytosis (3% of cases); and a decrease in the glucose level in blood serum. In chronic experiments on rabbits, the administration of noolit for 3 months in a dose of 0.5 and 2.0 g/kg (2 and 8 times that recommended for humans) did not reveal any toxic action on the functional and morphological state of the main systems and organs (blood, liver, kidneys, lungs, heart, gastrointestinal tract, sex organs, etc.).


Assuntos
Óxido de Alumínio/farmacologia , Enteroadsorção , Compostos de Lítio/farmacologia , Compostos de Organossilício/farmacologia , Óxido de Alumínio/toxicidade , Anemia/induzido quimicamente , Animais , Células Sanguíneas/efeitos dos fármacos , Glicemia/efeitos dos fármacos , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Feminino , Hematopoese/efeitos dos fármacos , Humanos , Compostos de Lítio/toxicidade , Masculino , Camundongos , Compostos de Organossilício/toxicidade , Coelhos , Ratos , Fatores de Tempo
2.
Radiats Biol Radioecol ; 36(5): 727-30, 1996.
Artigo em Russo | MEDLINE | ID: mdl-9019285

RESUMO

Male Wistar rats exposed to whole-body irradiation, the midline absorbed dose was 7.5 Gy. Full-sickness thermal burn 15% of body surface inflicted immediately after irradiation. Experimental study of the therapeutic efficacy of enterosorption alone or in combination with antibiotics doxycycline and ciprofloxacin performed. The strong decrease of bacterial endotoxemia, toxic oligopeptides' level and general blood toxicity revealed after treatment compared with non-treated animals with combined injuries. Corrections of postirradiation intestinal dysbacteriosis revealed too. The best result observed when carbon mineral sorbent and antibiotics administered daily within the first 10-14 days after combined injury. Survival of treated animals increased up to 80% (all rats of control group died during 30 days after combined injury).


Assuntos
Antibacterianos/uso terapêutico , Anti-Infecciosos/uso terapêutico , Queimaduras/terapia , Ciprofloxacina/uso terapêutico , Doxiciclina/uso terapêutico , Enteroadsorção , Lesões Experimentais por Radiação/terapia , Irradiação Corporal Total , Animais , Bactérias/isolamento & purificação , Queimaduras/complicações , Carbono , Terapia Combinada , Enteroadsorção/métodos , Intestinos/microbiologia , Masculino , Minerais , Doses de Radiação , Lesões Experimentais por Radiação/complicações , Ratos , Ratos Wistar , Fatores de Tempo
3.
Anesteziol Reanimatol ; (1): 60-2, 1996.
Artigo em Russo | MEDLINE | ID: mdl-8686948

RESUMO

SIAL, a new granulated white adsorbent, has been obtained. It is characterized by highly porous surface with hydrophilic-hydrophobic properties due to combined effects of the mineral matrix (aluminum oxide) and the coating (organosiloxane fluid) permitted for medical use. The detoxication properties of the adsorbent have been demonstrated in experimental hemosorption. It was shown to exert a moderate effect on the contact phase of blood clotting and on platelet aggregation characteristics.


Assuntos
Óxido de Alumínio/uso terapêutico , Hemoperfusão/métodos , Siloxanas/uso terapêutico , Óxido de Alumínio/farmacologia , Doadores de Sangue , Plaquetas/efeitos dos fármacos , Combinação de Medicamentos , Avaliação Pré-Clínica de Medicamentos , Hemostasia/efeitos dos fármacos , Humanos , Porosidade , Siloxanas/farmacologia
4.
Eksp Klin Farmakol ; 58(5): 65-7, 1995.
Artigo em Russo | MEDLINE | ID: mdl-8704596

RESUMO

The effect of enterosorbents of group "SUMS" on the manifestations of endogenous intoxication syndrome and dysfunction of small intestine was studied in rats with combined radiational-thermal injuries. The "SUMS" enterosorbents are shown to reduce the general toxemia, and promote the recovery of intestinal wall digestion enzyme activity and glucose absorption.


Assuntos
Queimaduras/terapia , Carvão Vegetal/uso terapêutico , Enteroadsorção/métodos , Minerais/uso terapêutico , Lesões Experimentais por Radiação/terapia , Animais , Avaliação Pré-Clínica de Medicamentos , Endotoxinas , Enteroadsorção/estatística & dados numéricos , Bactérias Gram-Negativas , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Porosidade , Ratos , Ratos Wistar , Toxemia/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA